Table 4 Alterations of renal function indexes during the treatment in two groups

eGFR (ml/min)^a,b

Baseline

49.62(34.76,58.65)

46.45(36.09,55.14)

0.294

16 weeks

47.55(34.5,56.91)

42.90(29.93,55.21)^**

0.120

creatine (umol/L)^a,b

Baseline

115.00(101.00,153.00)

123.00(106.00,159.00)

0.186

16 weeks

119.50(101.75,156.50)

129.50(106.00,177.50)^***

0.074

Uric acid (mmol/L)^a,b

Baseline

441.50(357.00,542.25)

444.00(338.00,530.50)

0.712

16 weeks

443.00(339.75,545.25)

439.00(361.75,518.50)

0.581